Search results
Health Care Roundup: Market Talk
The Wall Street Journal· 2 hours ago1016 ET – Drugmaker Kenvue expects China to continue to be a positive contributor to growth in 2024. CEO Thibaut Mongon on an investor call says there’s...
How One Drugmaker Plans To Cure Food Allergies
Bloomberg· 8 hours agoHello, everyone. Damian in Miami here. Reputable drug companies usually shy away from throwing around the word “cure.” But one drugmaker is starting to...
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
CNBC· 3 hours agoNovo Nordisk and Eli Lilly have long dominated the rapidly growing weight loss drug market, but...
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
Benzinga via Yahoo Finance· 2 hours agoTuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up...
At least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says
CNN via AOL· 5 days agoDrugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy,...
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
Reuters· 1 day agoIndian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its drugs in North America and domestic markets.
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 4 hours ago, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic drugmaker said on Tuesday, after it reported a ...
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
Benzinga via Yahoo Finance· 23 hours agoGossamer Bio Inc (NASDAQ:GOSS) and Italy-based Chiesi Farmaceutici S.p.A, have entered a global...
GSK profit drops in first quarter on higher costs
Digital Journal· 6 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters via Yahoo Finance· 4 days agoAmneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to...